Summary & Overview
HCPCS Level II J7506: Prednisone, Oral, per 5 mg
HCPCS Level II code J7506 designates prednisone oral, billed per 5 mg unit. Prednisone is a commonly prescribed systemic corticosteroid used across multiple clinical settings for inflammatory, allergic, and immune-mediated conditions. Nationally, accurate coding of oral pharmaceuticals like prednisone is important for consistent pharmacy billing, formulary management, utilization oversight, and cost-containment efforts.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise overview of billing considerations for payers and providers, typical sites of service for dispensing, and the clinical context in which prednisone is used. Readers will find benchmarks for coding practice, payer coverage considerations, and notes on where to find supporting clinical documentation. The report does not provide patient-specific guidance or clinical recommendations.
This summary serves clinicians, billing specialists, pharmacy managers, and policy analysts seeking a clear, national-level reference on HCPCS Level II code J7506 for prednisone, oral, per 5 mg.
Billing Code Overview
HCPCS Level II code J7506 represents Prednisone, oral, per 5 mg. This code denotes a unit of the oral corticosteroid prednisone, typically billed per 5 mg increment. The service type is a prescription oral medication dispensed for systemic anti-inflammatory and immunosuppressive therapy. The typical site of service is outpatient pharmacy dispensing or outpatient clinic administration where oral medications are provided to patients.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient receiving J7506 is an outpatient treated with oral prednisone tablets, billed per 5 mg unit, for short-term management of inflammatory or autoimmune conditions. A common scenario is an adult presenting to an ambulatory clinic or urgent care with an acute exacerbation of asthma, chronic obstructive pulmonary disease (COPD) flare, severe allergic reaction, or a rheumatoid arthritis flare requiring a defined short course of systemic corticosteroid therapy. The clinical workflow includes assessment by a prescriber (primary care, pulmonology, allergy/immunology, or rheumatology), determination of indication and dose, documentation of medical necessity and informed consent for systemic steroid therapy, electronic or handwritten prescription for prednisone (with dose expressed in 5 mg increments to align with J7506 billing units), dispensing by a pharmacy or clinic medication room, and follow-up instructions for tapering or monitoring adverse effects such as hyperglycemia, blood pressure elevation, mood changes, or infection risk. Typical sites of service include ambulatory clinic, urgent care, emergency department when issued at discharge, and inpatient hospital pharmacies when used as an outpatient discharge medication.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated evaluation and management service by the same physician during a postoperative period |